Citius Pharmaceuticals, Inc. ( CTXR) - Key Metrics
CTXR Revenue per Share metrics
| Date | Revenue per Share | Net Income per Share | Operating Cash Flow | Free Cash Flow per Share |
|---|---|---|---|---|
| 2026Q2 | ? | ? | ? | ? |
| 2026Q1 | $0.18 | -$0.44 | -$0.61 | -$0.61 |
| 2025Q4 | ? | -$0.44 | -$0.66 | -$0.66 |
| 2025Q3 | ? | -$0.80 | -$0.49 | -$0.49 |
| 2025Q2 | ? | -$0.94 | -$0.39 | -$0.39 |
CTXR Payout ratio and Price per Earnings ratio
| Date | Payout ratio | PE ratio |
|---|---|---|
| 2026Q2 | ? | ? |
| 2026Q1 | ? | -0.44 |
| 2025Q4 | ? | -0.70 |
| 2025Q3 | ? | -0.50 |
| 2025Q2 | ? | -0.40 |
CTXR
Price: $0.55
52 week price:
Earnings Per Share: -2.46 USD
Exchange: NCM
Sector: Healthcare
Industry: Biotechnology
Country: United States
Volume: 674400
Ebitda: -9.5 millionMarket Capitalization: 6.5 million